MILTENYI BIOTEC

Company Snapshot

Founded: 1989
Entity Type: Private
Employees: 5,000
Region: Germany
Headquarter: Bergisch Gladbach, Germany
Key Geographics: North America, Europe, Asia-Pacific
Corporate Address: Friedrich-Ebert-Straße 68 51429 Bergisch Gladbach Germany Tel. +49-2204-8306-0 www.miltenyibiotec.com

Company Overview

Miltenyi Biotec develops products and solutions to advance biomedical research and enable cell and gene therapy. Its flow cytometry portfolio includes instruments, reagents, kits and software for cell sorting and analysis. Additionally, it offers customized reagent solutions, such as antibodies and conjugates, tailored to clients’ specifications. Miltenyi Biotec's key technology includes its magnetic activated cell sorting (MACS) and analysis technology, which utilizes MACS microbeads, MACS columns and MACS separators for magnetic cell separation. It also offers industrial services, including contract manufacturing, reagents and disposables for the CliniMACS cell separation system (an automated cell selection device based on MACS technology), as well as cell culture and solutions. Miltenyi Biotec offers more than 19,000 products and services in sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis and preclinical imaging. It markets its products in 68 countries and has offices in 29 global locations.

MILTENYI BIOTEC In Reports

Cell and Gene Therapy Tools and Reagents: Global Markets

BCC Research detailed report on Cell and Gene Therapy Tools and Reagents Market covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2024 as...

Cell Therapy Processing: Global Markets and Technologies

BCC Research detailed report on cell therapy processing market includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

Global Cell Line and Membrane Market

According to BCC Research Cell Line and Membrane Market report includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through 2030.

Company's Business Segments

  • Cell and Gene Therapy (CGT) : The company offers cell separation technologies, cell analysis solutions, cell sorting platforms, cell and gene therapy manufacturing solutions, cell culture media and reagents, molecular biology and genomics products, immunology and stem cell research products, bioprocessing instruments and software, technical and laboratory services, and clinical and translational research solutions.

Applications/End User Industries

  • Immunology
  • Stem Cell Research
  • Oncology
  • Cell and Gene Therapy
  • Neuroscience
  • Cardiovascular
  • Immuno-Oncology
  • Hematopoietic
  • Mesenchymal Stem Cells
  • Tumor Cell
  • Isolation
  • Neurons
  • Neuroscientists
  • Microglia
  • Life Sciences
AI Sentiment